JPRN-UMIN000049961
Recruiting
未知
A pilot study of the safety and efficacy of stapler for transection of the pancreatic parenchyma during pancreaticoduodenectomy - A pilot study of the safety and efficacy of stapler for transection of the pancreatic parenchyma during pancreaticoduodenectomy
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Wakayama medical university
- Enrollment
- 15
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\) Patients with severe ischemic heart disease 2\) Patients with cirrhosis or active hepatitis 3\) Patients with dyspnea requiring oxygen administration due to interstitial pneumonia or pulmonary fibrosis 4\) Patients undergoing dialysis for chronic renal failure 5\) Cases requiring combined resection of surrounding organs 6\) Patients considered to require arterial reconstruction of the superior mesenteric artery, common hepatic artery, celiac artery, etc. 7\) Active double cancer that may affect adverse events or overall survival 8\) Long\-term oral steroid use that may affect adverse events 9\) Patients who are complicated by psychosis or psychiatric symptoms and judged to be difficult to participate in the study 10\) History of gastrectomy, colectomy or rectal resection 11\) Patients who cannot use both iodine\-based drugs and gadonium\-based drugs due to severe drug allergies
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Not Applicable
A phase I/II study of the efficacy and safety of an intensified schedule of Azacitidine (Vidaza®) in intermediate-2 and high risk MDS patients - GFM-Aza intensifEUCTR2010-020341-27-FRGroupe Francophone des Myélodysplasies
Completed
Phase 1
A phase I/II study for the safety and efficacy of Panitumumab in combination with TAS-102 for patients with RAS wild-type metastatic colorectal cancer refractory to standard chemotherapyunresectable advanced colorectal cancerJPRN-UMIN000019876Takeda Pharmaceutical Company Limited52
Completed
Not Applicable
A pilot study to evaluate efficacy and safety of sofosbuvir and daclatasvir for HCV genotype 3 infection in HIV and HCV co-infected hemophiliacsHIV infection, AIDS, Chronic hepatitis C infectionJPRN-UMIN000019659ational center for global health and medicine3
Completed
Not Applicable
Safety and efficacy of Transcend CyPass glaucoma implant in open angle glaucoma patients who have failed medical treatmentPrimary open angle glaucomaEye DiseasesGlaucomaISRCTN23263504Transcend Medical, Inc.™ (USA)20
Completed
Not Applicable
Transcend CyPass glaucoma implant and cataract surgery in open angle glaucoma patientsISRCTN86839890Transcend Medical, Inc.™ (USA)20